XML 42 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Financial Instruments
12 Months Ended
Oct. 31, 2021
Investments, All Other Investments [Abstract]  
Financial Instruments Financial Instruments
Cash Equivalents and Available-for-Sale Investments
Cash equivalents and available-for-sale investments were as follows:
 As of
October 31, 2021
As of
October 31, 2020
 CostGross
Unrealized
Gains
Fair
Value
CostGross
Unrealized
Gains
Fair
Value
 In millions
Cash Equivalents:      
Time deposits$806 $— $806 $939 $— $939 
Money market funds1,495 — 1,495 1,167 — 1,167 
Total cash equivalents2,301 — 2,301 2,106 — 2,106 
Available-for-Sale Investments:      
Foreign bonds108 14 122 108 17 125 
Other debt securities41 42 20 21 
Total available-for-sale investments149 15 164 128 18 146 
Total cash equivalents and available-for-sale investments$2,450 $15 $2,465 $2,234 $18 $2,252 
All highly liquid investments with original maturities of three months or less at the date of acquisition are considered cash equivalents. As of October 31, 2021 and 2020, the carrying amount of cash equivalents approximated fair value due to the short period of time to maturity. Interest income related to cash, cash equivalents and debt securities was approximately $18 million
in fiscal 2021, $44 million in fiscal 2020 and $64 million in fiscal 2019. Time deposits were primarily issued by institutions outside the U.S. as of October 31, 2021 and October 31, 2020. The estimated fair value of the available-for-sale investments may not be representative of values that will be realized in the future.
Contractual maturities of investments in available-for-sale debt securities were as follows:
 As of
October 31, 2021
 Amortized CostFair Value
 In millions
Due in one to five years26 26 
Due in more than five years123 138 
$149 $164 
Non-marketable equity investments in privately held companies are included in Long-term financing receivables and other assets in the Consolidated Balance Sheets. These non-marketable equity investments are carried either at fair value or under the measurement alternative.
The carrying amount of those non-marketable equity investments accounted for under the measurement alternative was $253 million and $295 million as of October 31, 2021 and 2020, respectively. During the twelve months ended October 31, 2021, the Company recorded an unrealized gain of $64 million on these investments.
The carrying amount of those non-marketable equity investments accounted for under the fair value option was $129 million as of October 31, 2021. During the twelve months ended October 31, 2021, the Company recorded an unrealized gain of $50 million on these investments.
Equity investments with readily determinable fair values are included in Long-term financing receivables and other assets in the Consolidated Balance Sheets. The carrying amount of such equity investments amounted to $57 million as of October 31, 2021. During the twelve months ended October 31, 2021, the Company recorded an unrealized gain of $25 million on these investments.
Investments in equity securities that are accounted for using the equity method are included in Investments in equity interests in the Consolidated Balance Sheets. These amounted to $2.2 billion at October 31, 2021 and 2020. For additional information, see Note 20, "Equity Method Investments".
Derivative Instruments
The Company is a global company exposed to foreign currency exchange rate fluctuations and interest rate changes in the normal course of its business. As part of its risk management strategy, the Company uses derivative instruments, primarily forward contracts, interest rate swaps and total return swaps to hedge certain foreign currency, interest rate and, to a lesser extent, equity exposures. The Company's objective is to offset gains and losses resulting from these exposures with losses and gains on the derivative contracts used to hedge them, thereby reducing volatility of earnings or protecting the fair value of assets and liabilities. The Company does not have any leveraged derivatives and does not use derivative contracts for speculative purposes. The Company may designate its derivative contracts as fair value hedges, cash flow hedges or hedges of the foreign currency exposure of a net investment in a foreign operation ("net investment hedges"). Additionally, for derivatives not designated as hedging instruments, the Company categorizes those economic hedges as other derivatives. Derivative instruments are recognized at fair value in the Consolidated Balance Sheets. The change in fair value of the derivative instruments is recognized in the Consolidated Statements of Earnings or Consolidated Statements of Comprehensive Income depending upon the type of hedge as further discussed below. The Company classifies cash flows from its derivative programs with the activities that correspond to the underlying hedged items in the Consolidated Statements of Cash Flows.
As a result of its use of derivative instruments, the Company is exposed to the risk that its counterparties will fail to meet their contractual obligations. To mitigate counterparty credit risk, the Company has a policy of only entering into derivative contracts with carefully selected major financial institutions based on their credit ratings and other factors, and the Company maintains dollar risk limits that correspond to each financial institution's credit rating and other factors. The Company's established policies and procedures for mitigating credit risk include reviewing and establishing limits for credit exposure and periodically reassessing the creditworthiness of its counterparties. Master netting agreements also mitigate credit exposure to counterparties by permitting the Company to net amounts due from the Company to a counterparty against amounts due to the Company from the same counterparty under certain conditions.
To further mitigate credit exposure to counterparties, the Company has collateral security agreements, which allows the Company to hold collateral from, or require the Company to post collateral to counterparties when aggregate derivative fair values exceed contractually established thresholds which are generally based on the credit ratings of the Company and its counterparties. If the Company's credit rating falls below a specified credit rating, the counterparty has the right to request full collateralization of the derivatives' net liability position. Conversely, if the counterparty's credit rating falls below a specified credit rating, the Company has the right to request full collateralization of the derivatives' net liability position. Collateral is generally posted within two business days. The fair value of the Company's derivatives with credit contingent features in a net liability position was $3 million and $45 million at October 31, 2021 and 2020, respectively, all of which were fully collateralized within two business days.
Under the Company's derivative contracts, the counterparty can terminate all outstanding trades following a covered change of control event affecting the Company that results in the surviving entity being rated below a specified credit rating. This credit contingent provision did not affect the Company's financial position or cash flows as of October 31, 2021 and 2020.
Fair Value Hedges
The Company issues long-term debt in U.S. dollars based on market conditions at the time of financing. The Company may enter into fair value hedges, such as interest rate swaps, to reduce the exposure of its debt portfolio to changes in fair value resulting from changes in interest rates by achieving a primarily U.S. dollar LIBOR-based floating interest rate. The swap transactions generally involve principal and interest obligations for U.S. dollar-denominated amounts. Alternatively, the Company may choose not to swap fixed for floating interest payments or may terminate a previously executed swap if it believes a larger proportion of fixed-rate debt would be beneficial. When investing in fixed-rate instruments, the Company may enter into interest rate swaps that convert the fixed interest payments into variable interest payments and may designate these swaps as fair value hedges.
For derivative instruments that are designated and qualify as fair value hedges, the Company recognizes the change in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Statements of Earnings in the period of change.
Cash Flow Hedges
The Company uses forward contracts designated as cash flow hedges to protect against the foreign currency exchange rate risks inherent in its forecasted net revenue and, to a lesser extent, cost of sales, operating expenses, and intercompany loans denominated in currencies other than the U.S. dollar. The Company's foreign currency cash flow hedges mature generally within twelve months; however, forward contracts associated with sales-type and direct-financing leases and intercompany loans extend for the duration of the lease or loan term, which can extend up to five years.
The Company uses interest rate contracts designated as cash flow hedges to hedge the variability of cash flows in the interest payments associated with its variable-rate debt due to changes in the U.S. dollar LIBOR-based floating interest rate. The swap transactions generally involve principal and interest obligations for U.S. dollar-denominated amounts.
For derivative instruments that are designated and qualify as cash flow hedges, and as long as they remain highly effective, the Company records the changes in fair value of the derivative instrument in Accumulated other comprehensive loss as a separate component of equity in the Consolidated Balance Sheets and subsequently reclassifies these amounts into earnings in the same financial statement line item when the hedged transaction is recognized.
Net Investment Hedges
The Company uses forward contracts designated as net investment hedges to hedge net investments in certain foreign subsidiaries whose functional currency is the local currency. The Company records the changes in the fair value of the hedged items in cumulative translation adjustment as a separate component of Equity in the Consolidated Balance Sheets.
Other Derivatives
Other derivatives not designated as hedging instruments consist primarily of forward contracts used to hedge foreign currency-denominated balance sheet exposures. The Company also uses total return swaps, based on equity or fixed income indices, to hedge its executive deferred compensation plan liability.
For derivative instruments not designated as hedging instruments, the Company recognizes changes in fair value of the derivative instrument, as well as the offsetting change in the fair value of the hedged item, in Interest and other, net in the Consolidated Statements of Earnings in the period of change.
Hedge Effectiveness
For interest rate swaps designated as fair value hedges, the Company measures hedge effectiveness by offsetting the change in fair value of the hedged items with the change in fair value of the derivative. For forward contracts designated as cash flow or net investment hedges, the Company measures hedge effectiveness by comparing the cumulative change in fair value of the hedge contract with the cumulative change in fair value of the hedged item, both of which are based on forward rates.
Fair Value of Derivative Instruments in the Consolidated Balance Sheets
The gross notional and fair value of derivative instruments in the Consolidated Balance Sheets was as follows:
As of
October 31, 2021
As of
October 31, 2020
 Fair Value Fair Value
Outstanding
Gross
Notional
Other
Current
Assets
Long-Term
Financing
Receivables
and Other
Assets
Other
Accrued
Liabilities
Long-Term
Other
Liabilities
Outstanding
Gross
Notional
Other
Current
Assets
Long-Term
Financing
Receivables
and Other
Assets
Other
Accrued
Liabilities
Long-Term
Other
Liabilities
 In millions
Derivatives designated as hedging instruments          
Fair value hedges:          
Interest rate contracts$3,850 $15 $80 $— $— $3,850 $— $220 $— 
Cash flow hedges:          
Foreign currency contracts7,664 125 68 49 32 7,652 75 85 95 38 
Interest rate contracts— — — — — 500 — — — 
Net investment hedges:          
Foreign currency contracts1,860 33 40 12 18 1,804 34 44 11 
Total derivatives designated as hedging instruments13,374 173 188 61 50 13,806 109 349 108 47 
Derivatives not designated as hedging instruments          
Foreign currency contracts6,994 25 17 16 — 6,157 43 35 
Other derivatives113 — — — 105 — — — 
Total derivatives not designated as hedging instruments7,107 29 17 16 — 6,262 43 38 
Total derivatives$20,481 $202 $205 $77 $50 $20,068 $152 $358 $146 $48 
Offsetting of Derivative Instruments
The Company recognizes all derivative instruments on a gross basis in the Consolidated Balance Sheets. The Company's derivative instruments are subject to master netting arrangements and collateral security arrangements. The Company does not offset the fair value of its derivative instruments against the fair value of cash collateral posted under collateral security agreements. As of October 31, 2021 and 2020, information related to the potential effect of the Company's use of the master netting agreements and collateral security agreements was as follows:
 As of
October 31, 2021
 In the Consolidated Balance Sheets  
 (i)(ii)(iii) = (i)–(ii)(iv)(v) (vi) = (iii)–(iv)–(v)
    Gross Amounts
Not Offset
  
 Gross
Amount
Recognized
Gross
Amount
Offset
Net Amount
Presented
DerivativesFinancial
Collateral
 Net Amount
 In millions
Derivative assets$407 $— $407 $123 $173 (1)$111 
Derivative liabilities$127 $— $127 $123 $(2)$(1)
 As of
October 31, 2020
 In the Consolidated Balance Sheets 
 (i)(ii)(iii) = (i)–(ii)(iv)(v)(vi) = (iii)–(iv)–(v)
    Gross Amounts
Not Offset
  
 Gross
Amount
Recognized
Gross
Amount
Offset
Net Amount
Presented
DerivativesFinancial
Collateral
 Net Amount
 In millions
Derivative assets$510 $— $510 $137 $321 (1)$52 
Derivative liabilities$194 $— $194 $137 $55 (2)$
(1)Represents the cash collateral posted by counterparties as of the respective reporting date for the Company's asset position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date.
(2)Represents the collateral posted by the Company in cash or through re-use of counterparty cash collateral as of the respective reporting date for the Company's liability position, net of derivative amounts that could be offset, as of, generally, two business days prior to the respective reporting date. As of October 31, 2021 and 2020 the entire amount of the collateral posted of $5 million and $55 million, respectively, was through re-use of counterparty collateral.
The amounts recorded on the Consolidated Balance Sheets related to cumulative basis adjustments for fair value hedges were as follows:
Carrying amount of the hedged assets/ (liabilities)Cumulative amount of fair value hedging adjustment included in the carrying amount of the hedged assets/ (liabilities)
As ofAs of
Balance Sheet Line Item of Hedged ItemOctober 31, 2021October 31, 2020October 31, 2021October 31, 2020
In millionsIn millions
Notes payable and short-term borrowings$(1,365)$— $(15)$— 
Long-term debt$(2,573)$(4,059)$(80)$(220)
The pre-tax effect of derivative instruments in cash flow and net investment hedging relationships recognized in Other Comprehensive Income ("OCI") were as follows:
Gains (Losses) Recognized in OCI on Derivatives
202120202019
In millions
Derivatives in Cash Flow Hedging relationship
Foreign exchange contracts$(50)$(34)$307 
Interest rate contracts— (6)
Derivatives in Net Investment Hedging relationship
Foreign exchange contracts(33)56 2
Total$(83)$16 $310 
As of October 31, 2021, the Company expects to reclassify an estimated net accumulated other comprehensive gain of approximately $57 million, net of taxes, to earnings in the next twelve months along with the earnings effects of the related forecasted transactions associated with cash flow hedges.
Effect of Derivative Instruments on the Consolidated Statements of Earnings
The pre-tax effect of derivative instruments on the Consolidated Statements of Earnings were as follows:
Gains (Losses) Recognized in Income
202120202019
Net revenueInterest and other, netNet revenueInterest and other, netNet revenueInterest and other, net
In millions
Total amounts of income and expense line items presented in the Consolidated Statements of Earnings in which the effects of fair value hedges, cash flow hedges and derivatives not designated as hedging instruments are recorded$27,784 $(211)$26,982 $(215)$29,135 $(177)
Gains (losses) on derivatives in fair value hedging relationships
Interest rate contracts
Hedged items$— $125 $— $(159)$— $(414)
Derivatives designated as hedging instruments— (125)— 159 — 414 
Gains (losses) on derivatives in cash flow hedging relationships
Foreign exchange contracts
Amount of gains (losses) reclassified from accumulated other comprehensive income into income(81)(73)38 (14)233 138 
Interest rate contracts
Amount of gains (losses) reclassified from accumulated other comprehensive income into income— (2)— (3)— — 
Gains (losses) on derivatives not designated as hedging instruments
Foreign exchange contracts— (68)— 44 — (134)
Other derivatives— — (5)— 
Total gains (losses)$(81)$(137)$38 $22 $233 $12